Severity Ranking of Missense and Frameshift Genetic Variants in SCD1 by In Silico and In Vitro Functional Analysis

Overview

Journal Nutrients

Date 2024 Oct 16

PMID 39408225

Authors

Hanna K Susan

Gabriella Orosz

Veronika Zambo

Miklos Csala

Eva Kereszturi

Affiliations

Soon will be listed here.

Abstract

Background: A considerable proportion of the symptoms associated with excessive dietary intake can be attributed to systemic imbalances in lipid metabolism. The prominent toxicity of saturated fatty acids has been repeatedly demonstrated and sheds light on the protective role of stearoyl-CoA desaturase-1 (SCD1), the key enzyme for fatty acid desaturation. SCD1 protein expression is regulated at the levels of transcription, translation, and degradation. However, the modulating effect of the variability of the human genome must also be taken into account. Therefore, we aimed to ascertain whether natural missense or frameshift mutations in SCD1 (p.H125P, p.M224L, p.A333T, p.R253AfsTer7) could influence the expression, degradation, or function of the enzyme.

Methods: In silico and in vitro experiments were conducted to comprehensively evaluate the consequences associated with each genetic variation, with the objective of using the results to propose a risk or severity ranking of SCD1 variants.

Results: As anticipated, the p.R253AfsTer7 variant was identified as the most deleterious in structural, functional, and quantitative terms. The p.H125P variant also reduced the desaturation capacity of the enzyme in accordance with the predicted structural alterations and augmented degradation resulting from folding complications. This was aggravated by increased mRNA instability and accompanied by mild endoplasmic reticulum stress induction. The p.A333T protein exhibited an intermediate phenotype, whereas p.M224L showed no deleterious effects and even increased the amount of SCD1.

Conclusions: In conclusion, the large-scale identification of genetic variations needs to be supplemented with comprehensive functional characterization of these variations to facilitate adequate personalized prevention and treatment of lipid metabolism-related conditions.

References

Martin-Nunez G, Cabrera-Mulero R, Rojo-Martinez G, Gomez-Zumaquero J, Chaves F, De Marco G . Polymorphisms in the SCD1 gene are associated with indices of stearoyl CoA desaturase activity and obesity: a prospective study. Mol Nutr Food Res. 2013; 57(12):2177-84. DOI: 10.1002/mnfr.201300208. View

Ding X, Singh P, Schimenti K, Tran T, Fragoza R, Hardy J . In vivo versus in silico assessment of potentially pathogenic missense variants in human reproductive genes. Proc Natl Acad Sci U S A. 2023; 120(30):e2219925120. PMC: 10372637. DOI: 10.1073/pnas.2219925120. View

Choi H, Andersen J, Molday R . Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders. Hum Mutat. 2019; 40(12):2353-2364. DOI: 10.1002/humu.23889. View

Stankova B, Macasek J, Zeman M, Vecka M, Tvrzicka E, Jachymova M . Polymorphisms rs2167444 and rs508384 in the SCD1 Gene Are Linked with High ApoB-48 Levels and Adverse Profile of Cardiometabolic Risk Factors. Folia Biol (Praha). 2020; 65(4):159-169. DOI: 10.14712/fb2019065040159. View

Han J, Kaufman R . The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016; 57(8):1329-38. PMC: 4959874. DOI: 10.1194/jlr.R067595. View

Zulkifli R, Parr T, Salter A, Brameld J . Regulation of ovine and porcine stearoyl coenzyme A desaturase gene promoters by fatty acids and sterols. J Anim Sci. 2010; 88(8):2565-75. DOI: 10.2527/jas.2009-2603. View

Kereszturi E, Szmola R, Kukor Z, Simon P, Weiss F, Lerch M . Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat. 2009; 30(4):575-82. PMC: 2663013. DOI: 10.1002/humu.20853. View

Kalman F, Lizak B, Nagy S, Meszaros T, Zambo V, Mandl J . Natural mutations lead to enhanced proteasomal degradation of human Ncb5or, a novel flavoheme reductase. Biochimie. 2013; 95(7):1403-10. DOI: 10.1016/j.biochi.2013.03.004. View

Turolo S, Edefonti A, Syren M, Marangoni F, Morello W, Agostoni C . Fatty Acids in Nephrotic Syndrome and Chronic Kidney Disease. J Ren Nutr. 2017; 28(3):145-155. DOI: 10.1053/j.jrn.2017.08.005. View

10.

Yao D, Luo J, He Q, Li J, Wang H, Shi H . Characterization of the liver X receptor-dependent regulatory mechanism of goat stearoyl-coenzyme A desaturase 1 gene by linoleic acid. J Dairy Sci. 2016; 99(5):3945-3957. DOI: 10.3168/jds.2015-10601. View

11.

Maedler K, Spinas G, Dyntar D, Moritz W, Kaiser N, Donath M . Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes. 2001; 50(1):69-76. DOI: 10.2337/diabetes.50.1.69. View

12.

Bogie J, Haidar M, Kooij G, Hendriks J . Fatty acid metabolism in the progression and resolution of CNS disorders. Adv Drug Deliv Rev. 2020; 159:198-213. DOI: 10.1016/j.addr.2020.01.004. View

13.

Tibori K, Zambo V, Orosz G, Szelenyi P, Sarnyai F, Tamasi V . Allele-specific effect of various dietary fatty acids and ETS1 transcription factor on SCD1 expression. Sci Rep. 2024; 14(1):177. PMC: 10761808. DOI: 10.1038/s41598-023-50700-5. View

14.

Talmud P, Humphries S . Gene:environment interaction in lipid metabolism and effect on coronary heart disease risk. Curr Opin Lipidol. 2002; 13(2):149-54. DOI: 10.1097/00041433-200204000-00006. View

15.

Schubach M, Maass T, Nazaretyan L, Roner S, Kircher M . CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 2024; 52(D1):D1143-D1154. PMC: 10767851. DOI: 10.1093/nar/gkad989. View

16.

Ordovas J, Robertson R, Ni Cleirigh E . Gene-gene and gene-environment interactions defining lipid-related traits. Curr Opin Lipidol. 2011; 22(2):129-36. DOI: 10.1097/MOL.0b013e32834477a9. View

17.

Lepage G, Roy C . Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986; 27(1):114-20. View

18.

Fretts A, Jensen P, Hoofnagle A, McKnight B, Howard B, Umans J . Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes. J Lipid Res. 2021; 62:100119. PMC: 8517199. DOI: 10.1016/j.jlr.2021.100119. View

19.

Gong J, Campos H, McGarvey S, Wu Z, Goldberg R, Baylin A . Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in Costa Rican adults. J Nutr. 2011; 141(12):2211-8. PMC: 3223878. DOI: 10.3945/jn.111.143503. View

20.

Perna M, Hewlings S . Saturated Fatty Acid Chain Length and Risk of Cardiovascular Disease: A Systematic Review. Nutrients. 2023; 15(1). PMC: 9823926. DOI: 10.3390/nu15010030. View